Skip to content
Medical Health Aged Care

Registrar Corp Acquires CMC Medical Devices to Make Global Compliance Quick and Easy

Registrar Corp 2 mins read

Expands Registrar Corp’s reach to support over 75% of the global medical device market.


MALAGA, Spain & HAMPTON, Va.--BUSINESS WIRE--

Registrar Corp, a global leader in regulatory compliance and technology solutions and a Paine Schwartz Partners portfolio company, today announced the acquisition of CMC Medical Devices (CMC), a Spain-based provider of medical device regulatory, clinical, and compliance consulting services. The combination of Registrar Corp’s global network and CMC’s clinical and technical expertise creates a unified partner to help medical device and in vitro diagnostic (IVD) manufacturers bring products to market faster and with greater confidence.

“We’re proud to welcome CMC Medical Devices to the Registrar Corp family,” said Raj Shah, CEO of Registrar Corp. “Together, we offer medical device manufacturers a single partner to navigate complex regulations and access the U.S., EU, and other key global markets—so they can focus on innovation rather than compliance.”

“Joining Registrar Corp enables us to deliver even greater value to our clients,” said Manuel Mateos, CEO of CMC Medical Devices. “Our shared mission is to help manufacturers reach patients faster with trusted, region-specific compliance support.”

The acquisition expands Registrar Corp’s capabilities across multiple service areas, including:

  • Global Representation: Authorized representative and sponsor services in the EU, UK, Switzerland, Australia, the United States, and China, helping manufacturers maintain compliance in every market.
  • Export and Market Access Support: Management of Free Sale Certificates (FSCs) from major jurisdictions to streamline export documentation and accelerate product approvals.
  • Clinical and Regulatory Support: Through CMC’s clinical partner network, Registrar Corp now offers clinical evaluation documentation, data collection planning, post-market clinical follow-up (PMCF) reporting, and comprehensive MDR/IVDR guidance.

This acquisition reinforces Registrar Corp’s commitment to simplifying international expansion for manufacturers—reducing complexity, cost, and time to market. With integrated regulatory, clinical, and compliance services, medical device and IVD companies can now rely on one trusted partner for every stage of product compliance and commercialization.

About Registrar Corp

Registrar Corp provides regulatory compliance and technology solutions to over 32,000 clients across 190 countries, supporting industries including medical devices, food and beverage, cosmetics, and over-the-counter drugs.

About CMC Medical Devices

CMC Medical Devices is a global regulatory consulting firm serving medical device and IVD manufacturers in more than 70 countries, specializing in MDR and IVDR compliance, authorized representation, and regulatory strategy.


Contact details:

Media Contact:
Kelly Potts
[email protected]

Media

More from this category

  • Medical Health Aged Care
  • 22/01/2026
  • 17:11
Galderma

IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio

At IMCAS 2026, Galderma will present findings supporting Sculptra’s® regenerative properties and benefits on the body, including improving cellulite appearance, firmness, lift, projection, and…

  • Contains:
  • Medical Health Aged Care
  • 22/01/2026
  • 16:36
Dementia Australia

Get active for your brain health and beat dementia in Canberra!

The 2026 Canberra Memory Walk & Jog is just weeks away, with the event taking place on Sunday 22 February at Stage 88, Commonwealth Park. As Dementia Australia’s largest annual fundraising initiative, Memory Walk & Jog brings communities together to get active, get connected and support Australians living with dementia, their families and carers. More than 6,100 people live with dementia in the Australian Capital Territory. Dementia is now the leading cause of death for Australians, and without significant intervention, the number of Australians living with dementia is expected to increase to more than one million by 2065. In 2026,…

  • Contains:
  • Medical Health Aged Care, Science
  • 22/01/2026
  • 10:00
Monash University

Patients co-design world-first clinical trial to determine if invasive heart surgery monitoring helps or harms patients

Australians undergoing open-heart surgery could soon benefit from safer, simpler care and get home earlier thanks to the results of a world-first clinical trial…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.